Search Term:

*


June 1, 2021: Precision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform.

April 1, 2021: Major capacity expansion underway to support increase in industry demand

March 31, 2021: New acquisition will help support single-use technology demand driven by COVID-19

January 7, 2021: Pall Corporation expands production capacity in the United States and Europe to support industry demand

Pall joins a consortium led by Oxford University in fast-tracking clinical trials for a COVID-19 vaccine beginning April 2020.

July 16, 2019: Servier chooses Pall as exclusive technology and services provider for planned Bio-S biomanufacturing facility in France

April 29, 2019: Freeline's (AAV) manufacturing platform and Pall’s iCELLis bioreactor system combine to achieve commercial-scale and high quality production of AAV gene therapy vectors